Ross Berkowitz, MD, is the co-director of the New England Trophoblastic Disease Center at Dana-Farber/Brigham and Women's Cancer Center, affiliated with the Susan F. Smith Center for Women's Cancers. For over 20 years, Dr. Berkowitz has focused his research and care on GTD, and has published more than 250 original reports and reviews on this disease – including his studies of risk factors and improved therapies.
Donald Peter Goldstein, MD, founded the New England Trophoblastic Disease Center in 1965 and serves as co-director. Dr. Goldstein's major research interest has been the early diagnosis of gestational trophoblastic tumors using the BhCG test. This has enabled early intervention and improved outcomes in patients who develop trophoblastic tumors following molar and non-molar pregnancies. He also helped to develop a practical staging system for trophoblastic tumors, which allows better selection of therapeutic protocols based on severity of the disease.
Neil Horowitz, MD, is a board certified gynecologic oncologist who practices closely with the founders of the New England Trophoblastic Disease Center. As Director of Clinical Research in Gynecologic Oncology, Dr. Horowitz's work has included several ongoing research projects on GTD.
Ursula Matulonis, MD, is medical director and program leader of the Medical Gynecologic Oncology Program at the Susan F. Smith Center for Women's Cancers at Dana-Farber and associate professor of medicine at Harvard Medical School. Her research focuses on targeted therapies for gynecologic malignancies, with a specific interest in the genetic changes in ovarian cancer and how these can lead to rational targeted drug selection.
Akila Viswanathan, MD, is the director of Gynecologic Radiation Oncology. She specializes in gynecologic malignancies and image-guided brachytherapy.
Lisa B. Arvine, NP
Debra Cotto, RN
Kathleen Juliano, RN
Stephanie Morrisey, NP
Ann-Marie C. Wilson, NP
Marilyn R. Bernstein, MHP
Your entire care team has extensive experience in caring for patients with gynecologic cancers. Our specialists work closely together and collaborate regularly to ensure that your care plan offers the best possible outcomes and that all your needs are met.
Learn more about our team of gynecological cancer specialists.